Mitochondrial Common Deletion, a Potential Biomarker for Cancer Occurrence, Is Selected against in Cancer Background: A Meta-Analysis of 38 Studies

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Nie, Hezhongrong ^a   Shu, Hongying ^a   Vartak, Rasika ^b   Milstein, Amanda Claire ^b   Mo, Yalin ^a   Hu, Xiaoqin ^a   Fang, Hezhi ^a   Shen, Lijun ^a   Ding, Zhinan ^a   Lu, Jianxin ^a   Bai, Yidong ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; BREAST CANCER; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE MARKER; DNA DETERMINATION; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; TISSUE LEVEL;

AGED; CASE-CONTROL STUDIES; DATABASES, BIBLIOGRAPHIC; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MALE; MITOCHONDRIA; NEOPLASMS; ODDS RATIO; SAMPLE SIZE; SEQUENCE DELETION; TUMOR MARKERS, BIOLOGICAL;

EID: 84879816898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067953     Document Type: Article

References (70)

1. Attardi G, Schatz G, (1988) Biogenesis of mitochondria. Annu Rev Cell Biol 4: 289-333.
2. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, et al. (1981) Sequence and organization of the human mitochondrial genome. Nature 290: 457-465.
3. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, et al. (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23: 147.
4. Howell N, Kubacka I, Mackey DA, (1996) How rapidly does the human mitochondrial genome evolve? Am J Hum Genet 59: 501-509.
5. Taylor RW, Turnbull DM, (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6: 389-402.
6. Warburg O, (1956) On respiratory impairment in cancer cells. Science 124: 269-270.
7. Brandon M, Baldi P, Wallace DC, (2006) Mitochondrial mutations in cancer. Oncogene 25: 4647-4662.
8. Chatterjee A, Mambo E, Sidransky D, (2006) Mitochondrial DNA mutations in human cancer. Oncogene 25: 4663-4674.
9. Czarnecka AM, Golik P, Bartnik E, (2006) Mitochondrial DNA mutations in human neoplasia. J Appl Genet 47: 67-78.
10. Maitra A, Cohen Y, Gillespie SE, Mambo E, Fukushima N, et al. (2004) The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res 14: 812-819.
11. Frenny VJ, Antonella Z, Luisa A, Shah AD, Sheth JJ, et al. (2003) Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies. Indian J Cancer 40: 135-139.
12. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, et al. (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287: 2017-2019.
13. Cortopassi GA, Arnheim N, (1990) Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 18: 6927-6933.
14. Peng TI, Yu PR, Chen JY, Wang HL, Wu HY, et al. (2006) Visualizing common deletion of mitochondrial DNA-augmented mitochondrial reactive oxygen species generation and apoptosis upon oxidative stress. Biochim Biophys Acta 1762: 241-255.
15. Holt IJ, Harding AE, Cooper JM, Schapira AH, Toscano A, et al. (1989) Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 26: 699-708.
16. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, McKee AC, et al. (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23: 471-476.
17. Berneburg M, Gattermann N, Stege H, Grewe M, Vogelsang K, et al. (1997) Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic system. Photochem Photobiol 66: 271-275.
18. Berneburg M, Grether-Beck S, Kurten V, Ruzicka T, Briviba K, et al. (1999) Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem 274: 15345-15349.
19. Wallace DC, Shoffner JM, Trounce I, Brown MD, Ballinger SW, et al. (1995) Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta 1271: 141-151.
20. Shen L, Fang H, Chen T, He J, Zhang M, et al. (2010) Evaluating mitochondrial DNA in cancer occurrence and development. Ann N Y Acad Sci 1201: 26-33.
21. Meissner C, Bruse P, Mohamed SA, Schulz A, Warnk H, et al. (2008) The 4977 bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: a useful biomarker or more? Exp Gerontol 43: 645-652.
22. Lu J, Sharma LK, Bai Y, (2009) Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res 19: 802-815.
23. Lee HC, Wei YH, (2009) Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci 10: 674-701.
24. Dani SU, Dani MA, Simpson AJ, (2003) The common mitochondrial DNA deletion deltamtDNA(4977): shedding new light to the concept of a tumor suppressor mutation. Med Hypotheses 61: 60-63.
25. Aral C, Akkiprik M, Kaya H, Ataizi-Celikel C, Caglayan S, et al. (2010) Mitochondrial DNA common deletion is not associated with thyroid, breast and colorectal tumors in Turkish patients. Genet Mol Biol 33: 1-4.
26. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
27. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
28. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
29. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
30. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
31. Zhu W, Qin W, Sauter ER, (2004) Large-scale mitochondrial DNA deletion mutations and nuclear genome instability in human breast cancer. Cancer Detect Prev 28: 119-126.
32. Pavicic WH, Richard SM, (2009) Correlation analysis between mtDNA 4977-bp deletion and ageing. Mutat Res 670: 99-102.
33. Tseng LM, Yin PH, Tsai YF, Chi CW, Wu CW, et al. (2009) Association between mitochondrial DNA 4,977 bp deletion and NAD(P)H:quinone oxidoreductase 1 C609T polymorphism in human breast tissues. Oncol Rep 21: 1169-1174.
34. Ye C, Shu XO, Wen W, Pierce L, Courtney R, et al. (2008) Quantitative analysis of mitochondrial DNA 4977-bp deletion in sporadic breast cancer and benign breast diseases. Breast Cancer Res Treat 108: 427-434.
35. Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, et al. (2006) Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer 45: 629-638.
36. Tan DJ, Bai RK, Wong LJ, (2002) Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62: 972-976.
37. Bianchi MS, Bianchi NO, Bailliet G, (1995) Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet 71: 99-103.
38. Dani MA, Dani SU, Lima SP, Martinez A, Rossi BM, et al. (2004) Less DeltamtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet Mol Res 3: 395-409.
39. Gwak GY, Lee DH, Moon TG, Choi MS, Lee JH, et al. (2011) The correlation of hepatitis B virus pre-S mutation with mitochondrial D-loop mutations and common deletions in hepatocellular carcinoma. Hepatogastroenterology 58: 522-528.
40. Wheelhouse NM, Lai PB, Wigmore SJ, Ross JA, Harrison DJ, (2005) Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver. Br J Cancer 92: 1268-1272.
41. Fukushima S, Honda K, Awane M, Yamamoto E, Takeda R, et al. (1995) The frequency of 4977 base pair deletion of mitochondrial DNA in various types of liver disease and in normal liver. Hepatology 21: 1547-1551.
42. Yin PH, Lee HC, Chau GY, Wu YT, Li SH, et al. (2004) Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer 90: 2390-2396.
43. Shao JY, Gao HY, Li YH, Zhang Y, Lu YY, et al. (2004) Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia. World J Gastroenterol 10: 1560-1564.
44. Wang J, Lu YY, (2009) Mitochondrial DNA 4977-bp deletion correlated with reactive oxygen species production and manganese superoxidedismutase expression in gastric tumor cells. Chin Med J (Engl) 122: 431-436.
45. Wu CW, Yin PH, Hung WY, Li AF, Li SH, et al. (2005) Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer 44: 19-28.
46. Kamalidehghan B, Houshmand M, Ismail P, Panahi MS, Akbari MH, (2006) Delta mtDNA4977 is more common in non-tumoral cells from gastric cancer sample. Arch Med Res 37: 730-735.
47. Chen T, He J, Shen L, Fang H, Nie H, et al. (2011) The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med Genet 12: 8.
48. Upadhyay R, Jain M, Kumar S, ChandGhoshal U, Mittal B, (2009) Role of mitochondrial DNA 4977-bp deletions in esophageal cancer susceptibility and prognosis in a northern Indian population. Cancer Genet Cytogenet 195: 175-178.
49. Abnet CC, Huppi K, Carrera A, Armistead D, McKenney K, et al. (2004) Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer 4: 30.
50. Tan BH, Skipworth RJ, Stephens NA, Wheelhouse NM, Gilmour H, et al. (2009) Frequency of the mitochondrial DNA 4977 bp deletion in oesophageal mucosa during the progression of Barrett's oesophagus. Eur J Cancer 45: 736-740.
51. Lee HC, Yin PH, Yu TN, Chang YD, Hsu WC, et al. (2001) Accumulation of mitochondrial DNA deletions in human oral tissues - effects of betel quid chewing and oral cancer. Mutat Res 493: 67-74.
52. Rahul Pandey DM CC, Vimal Choubey, Rajiv Sarin, Abbas Ali Mahdi, et al. (2012) Association of mitochondrial deoxyribonucleic acid mutation with polymorphism in CYP2E1 gene in oral carcinogenesis. Journal of Oral Biology and Craniofacial Research 2: 4-9.
53. Tan DJ CJ, Chen WL, Agress LJ, Yeh KT, et al. (2003) Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers. Genes Chromosomes Cancer 37: 186-194.
54. Maximo V SP, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M, (2002) Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol 160: 1857-1865.
55. Yang JH, Lee HC, Chung JG, Wei YH, (2004) Mitochondrial DNA mutations in light-associated skin tumors. Anticancer Res 24: 1753-1758.
56. Kamenisch Y, Wenz J, Metzler G, Bauer J, Neubauer H, et al. (2007) The mitochondrial DNA common deletion is present in most basal and squamous cell carcinoma samples isolated by laser capture microdissection but generally at reduced rather than increased levels. J Invest Dermatol 127: 486-490.
57. Futyma K, Putowski L, Cybulski M, Miotla P, Rechberger T, et al. (2008) The prevalence of mtDNA4977 deletion in primary human endometrial carcinomas and matched control samples. Oncol Rep 20: 683-688.
58. Dai JG, Xiao YB, Min JX, Zhang GQ, Yao K, et al. (2006) Mitochondrial DNA 4977 BP deletion mutations in lung carcinoma. Indian J Cancer 43: 20-25.
59. Lewis PD, Baxter P, Paul Griffiths A, Parry JM, Skibinski DO, (2000) Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin's tumour. J Pathol 191: 274-281.
60. Kara M TA, Borekci B, Dagli F, Oztas S, (2012) Mitochondrial DNA 4977 bp deletion in chronic cervicitis and cervix cancers. Balkan Journal of Medical Genetics 15: 25-29.
61. Wen Q, Hu Y, Ji F, Qian G, (2011) Mitochondrial DNA alterations of peripheral lymphocytes in acute lymphoblastic leukemia patients undergoing total body irradiation therapy. Radiat Oncol 6: 133.
62. Yu JJ, Yan T, (2010) Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer. Aging Male 13: 159-165.
63. Tan DJ, Chang J, Liu LL, Bai RK, Wang YF, et al. (2006) Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer. BMC Cancer 6: 93.
64. Rogounovitch TI, Saenko VA, Shimizu-Yoshida Y, Abrosimov AY, Lushnikov EF, et al. (2002) Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors. Cancer Res 62: 7031-7041.
65. Kao S, Chao HT, Wei YH, (1995) Mitochondrial deoxyribonucleic acid 4977-bp deletion is associated with diminished fertility and motility of human sperm. Biol Reprod 52: 729-736.
66. Shenkar R, Navidi W, Tavare S, Dang MH, Chomyn A, et al. (1996) The mutation rate of the human mtDNA deletion mtDNA4977. Am J Hum Genet 59: 772-780.
67. Thayer RE, Wittock R, Parr R, Zullo S, Birch-Machin MA, (2003) A maternal line study investigating the 4977-bp mitochondrial DNA deletion. Exp Gerontol 38: 567-571.
68. Wang E, Wong A, Cortopassi G, (1997) The rate of mitochondrial mutagenesis is faster in mice than humans. Mutat Res 377: 157-166.
69. Lee HC, Hsu LS, Yin PH, Lee LM, Chi CW, (2007) Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion. Mitochondrion 7: 157-163.
70. Park JS, Sharma LK, Li H, Xiang R, Holstein D, et al. (2009) A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet 18: 1578-1589.